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Schizophrenia is a progressive illness, with many psy-
chotic episodes. Brain imaging studies have consistently
demonstrated brain abnormalities in patients with schi-
zophrenia. These changes are largely confined to
decreases in gray matter volumes and enlargement of
the lateral and third ventricles. To date schizophrenia
has been considered to result from abnormalities in
neurodevelopment, with brain changes to be static.
However, schizophrenia has long been thought to be a
progressive or a degenerative, not a developmental, dis-
order. Indeed, Kraepelin considered the progressive clin-
ical deterioration to be the hallmark of the disorder,
naming it dementia praecox to reflect this particular
aspect. Lately, others have re-emphasized the impor-
tance of the decline in functioning in schizophrenia as a
clue to its pathogenesis, suggesting that the brain
abnormalities in schizophrenia could be expected to
reflect this clinical progression. Indeed, we and others
have reported brain abnormalities to increase over time
in schizophrenia. Interestingly, not all patients show
changes in brain volumes over time: we demonstrated
that the changes are particularly pronounced in those
patients with a poor prognosis in the first years of ill-
ness. Moreover progressive changes are most pro-
nounced in the frontal and temporal areas as postulated
by Kraepelin over a hundred years ago. Interestingly,
white matter did not change over time. Also we found
that brain loss over time was most pronounced in
patients who had been psychotic longest. Finally, the
progression in these frontal brain changes appeared to
be attenuated by treatment with atypical, but not by
typical antipsychotics. Thus, not only are brain changes
progressive in schizophrenia, they are clinically relevant
since they are related to outcome and may be reversed
by some of the atypical antipsychotics. With the evi-
dence pointing to a link between progressive disease
and patient outcomes, it is becoming increasingly clear
that every effort should be made to prevent psychotic
relapses. Using medications with maximal effect is
therefore warranted.
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